TEHRAN (ANA)- Researchers at UVA Health have uncovered a potential explanation for some of the most puzzling aspects of COVID-19 and long COVID and the surprising insights may pave the way for novel treatments targeting the challenging acute impacts of COVID-19, long COVID, and potentially other viruses.
TEHRAN (ANA)- A new study by Columbia researchers now shows that far-UVC light inactivated nearly all (>99%) of an airborne virus in an occupied work environment, showing that the technology can work as well in a real-life scenario as in the laboratory.
TEHRAN (ANA)- Research teams led by Dirk Görlich at the Max Planck Institute for Multidisciplinary Science and Thomas Schwartz at the Massachusetts Institute of Technology (MIT) have discovered that the HIV virus capsid has evolved into a molecular transporter.
TEHRAN (ANA)- Recent research by the NYU Grossman School of Medicine demonstrates that blocking the attachment of virus particles to cell surface molecules in infant mice can significantly reduce the transmission of influenza A.
TEHRAN (ANA)- The head of the Pasteur Institute of Iran said that the researchers at the famous Iranian research center have managed to produce vaccines against bladder cancer and Pasteurellosis.
TEHRAN (ANA)- About one in nine adults in the United States who have ever had COVID-19 continue to experience Long COVID with a wide range of symptoms, according to new data of the U.S. Centers for Disease Control and Prevention (CDC).
TEHRAN (ANA)- MIT and Ragon Institute scientists created a DNA-based vaccine that elicits a potent antibody response against SARS-CoV-2 and this approach, which focuses the immune response on the target antigen, could revolutionize vaccine development for various challenging viruses.
TEHRAN (ANA)- A global fight against measles faces setbacks from vaccine hesitancy, highlighting the need for increased adult vaccination to protect against outbreaks.
TEHRAN (ANA)- Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study, according to the U.S. National Institutes of Health (NIH).